ATE543500T1 - Kombinationen mit 5ht6-modulatoren und cholinesterase-hemmern - Google Patents
Kombinationen mit 5ht6-modulatoren und cholinesterase-hemmernInfo
- Publication number
- ATE543500T1 ATE543500T1 AT07796424T AT07796424T ATE543500T1 AT E543500 T1 ATE543500 T1 AT E543500T1 AT 07796424 T AT07796424 T AT 07796424T AT 07796424 T AT07796424 T AT 07796424T AT E543500 T1 ATE543500 T1 AT E543500T1
- Authority
- AT
- Austria
- Prior art keywords
- modulators
- combinations
- cholinesterase inhibitors
- cholinesterase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US81651706P | 2006-06-26 | 2006-06-26 | |
| PCT/US2007/014747 WO2008002539A1 (en) | 2006-06-26 | 2007-06-26 | Combinations comprising 5ht6 modulators and cholinesterase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543500T1 true ATE543500T1 (de) | 2012-02-15 |
Family
ID=38611041
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07796424T ATE543500T1 (de) | 2006-06-26 | 2007-06-26 | Kombinationen mit 5ht6-modulatoren und cholinesterase-hemmern |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100152141A1 (de) |
| EP (1) | EP2037925B1 (de) |
| JP (1) | JP2009541484A (de) |
| AR (1) | AR061637A1 (de) |
| AT (1) | ATE543500T1 (de) |
| AU (1) | AU2007265515A1 (de) |
| CA (1) | CA2655828A1 (de) |
| MX (1) | MX2008015860A (de) |
| TW (1) | TW200808743A (de) |
| WO (1) | WO2008002539A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488736B2 (en) | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
| US7598265B2 (en) | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
| US20090221554A1 (en) * | 2008-02-28 | 2009-09-03 | Zenyaku Kogyo Kabushiki Kaisha | Method of treating cognitive impairment |
| WO2010065743A2 (en) | 2008-12-03 | 2010-06-10 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
| EP2412705B1 (de) * | 2009-03-26 | 2014-05-07 | Dainippon Sumitomo Pharma Co., Ltd. | Neues therapeutikum für kognitive beeinträchtigung |
| AU2012321345B2 (en) | 2011-10-03 | 2016-03-17 | The University Of Utah Research Foundation | Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| WO2014165701A1 (en) * | 2013-04-03 | 2014-10-09 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| JO3459B1 (ar) | 2012-09-09 | 2020-07-05 | H Lundbeck As | تركيبات صيدلانية لعلاج مرض الزهايمر |
| WO2016179569A1 (en) * | 2015-05-07 | 2016-11-10 | Axovant Sciences Ltd. | Compositions and methods of treating a neurodegenerative disease |
| US10864191B2 (en) | 2016-05-11 | 2020-12-15 | H. Lundbeck A/S | 5-HT6 receptor antagonists for use in the treatment of Alzheimer's disease with apathy as comorbidity |
| KR102015484B1 (ko) | 2016-05-18 | 2019-08-28 | 수벤 라이프 사이언시스 리미티드 | 순수한 5-ht6 수용체 길항제와 아세틸콜린에스테라제 저해제의 조합물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA03006605A (es) * | 2001-01-30 | 2003-09-22 | Lilly Co Eli | Esteres de indol-5-ilo del acido bencensulfonico como antagonistas del receptor 5-ht6. |
| HRP20070241T3 (hr) * | 2003-12-19 | 2007-07-31 | Bristol-Myers Squibb Company | Azabiciklički heterocikli kao modulatori kanabinoid receptora |
| JP5186219B2 (ja) * | 2005-01-25 | 2013-04-17 | エピックス デラウェア, インコーポレイテッド | 置換アリールアミン化合物および5−ht6調節因子としてのその使用 |
| PE20071143A1 (es) * | 2006-01-13 | 2008-01-20 | Wyeth Corp | Composicion farmaceutica que comprende un inhibidor de acetilcolinesterasa y un antagonista 5-hidroxitriptamina-6 |
| EP2020230B1 (de) * | 2007-08-01 | 2011-01-19 | Laboratorios del Dr. Esteve S.A. | Kombination von mindestens zwei 5-HT6-Liganden |
-
2007
- 2007-06-25 AR ARP070102816A patent/AR061637A1/es not_active Application Discontinuation
- 2007-06-26 TW TW096123097A patent/TW200808743A/zh unknown
- 2007-06-26 EP EP07796424A patent/EP2037925B1/de not_active Not-in-force
- 2007-06-26 AT AT07796424T patent/ATE543500T1/de active
- 2007-06-26 MX MX2008015860A patent/MX2008015860A/es active IP Right Grant
- 2007-06-26 CA CA002655828A patent/CA2655828A1/en not_active Abandoned
- 2007-06-26 WO PCT/US2007/014747 patent/WO2008002539A1/en not_active Ceased
- 2007-06-26 AU AU2007265515A patent/AU2007265515A1/en not_active Abandoned
- 2007-06-26 US US12/306,301 patent/US20100152141A1/en not_active Abandoned
- 2007-06-26 JP JP2009518206A patent/JP2009541484A/ja not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| TW200808743A (en) | 2008-02-16 |
| CA2655828A1 (en) | 2008-01-03 |
| AU2007265515A1 (en) | 2008-01-03 |
| US20100152141A1 (en) | 2010-06-17 |
| JP2009541484A (ja) | 2009-11-26 |
| EP2037925A1 (de) | 2009-03-25 |
| EP2037925B1 (de) | 2012-02-01 |
| WO2008002539A1 (en) | 2008-01-03 |
| AR061637A1 (es) | 2008-09-10 |
| MX2008015860A (es) | 2009-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI20075978A0 (fi) | Järjestely ja menetelmä | |
| ATE477312T1 (de) | Flüssigkeitshärtung | |
| EP2061866A4 (de) | Schnelles thermocycler-gerät | |
| BRPI0910925A2 (pt) | conjuntos de transferência de líquido e métodos relacionados | |
| EP2047502A4 (de) | Nanokristallbildung | |
| ATE479736T1 (de) | Cholesterische mehrschichten | |
| DE602007009238D1 (de) | Biplanare elektrode mit sperr-gates | |
| FI20075532A0 (fi) | Uusia esteraaseja ja niiden käyttö | |
| DE602007012419D1 (de) | Hochfestes haftpolymergel und klebeband | |
| DK1989206T3 (da) | E1-aktiveringsenzymhæmmere | |
| BRPI0809978A2 (pt) | Dispositivos e métodos de dispensação de gotículas | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| EP2122054A4 (de) | Vliestafel und konstruktionsverfahren dafür | |
| HRP20141261T1 (xx) | Spojevi tioninija i njihove uporabe | |
| NO20090079L (no) | Arylsulfonamider med analgesisk virkning | |
| DE602007000495D1 (de) | Flüssigkeit-Koinfusionsgerät | |
| FI20065359L (fi) | Menetelmä ja rannelaite | |
| EP1841794A4 (de) | Adam-9-modulatoren | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| CR10430A (es) | Aminothiazoles and their uses | |
| EP2044097A4 (de) | Modifizierte ribonukleasen | |
| BRPI0715508A2 (pt) | Dispositivos e métodos de plantio | |
| EP2054074A4 (de) | Modifiziertes erythropoietin | |
| EP1915162A4 (de) | Modulatoren |